[A multicenter, double-blind, randomized, placebo-controlled clinical trial of etanercept treatment of Chinese patients with active ankylosing spondylitis].

Zhonghua nei ke za zhi [Chinese journal of internal medicine]

Volumn 50, Issue 12, 2011, Pages 1043-1047

  Huang, Feng ^a   Zhang, Jie ^b   Zheng, Y ^b   Xu, Jian hua ^b   Li, Xing fu ^b   Wu, Hua xiang ^b   Chen, Zhi wei ^b   Zhao, Zheng ^b   Zhang, Ya mei ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862286739     PISSN: 05781426     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)